Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myriad Genetics (MYGN) Shares Outstanding (Weighted Average): 2009-2024

Historic Shares Outstanding (Weighted Average) for Myriad Genetics (MYGN) over the last 16 years, with Dec 2024 value amounting to $91.0 million.

  • Myriad Genetics' Shares Outstanding (Weighted Average) rose 2.45% to $93.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $93.0 million, marking a year-over-year increase of 2.45%. This contributed to the annual value of $91.0 million for FY2024, which is 10.75% up from last year.
  • According to the latest figures from FY2024, Myriad Genetics' Shares Outstanding (Weighted Average) is $91.0 million, which was up 10.75% from $82.2 million recorded in FY2023.
  • In the past 5 years, Myriad Genetics' Shares Outstanding (Weighted Average) registered a high of $91.0 million during FY2024, and its lowest value of $74.6 million during FY2020.
  • For the 3-year period, Myriad Genetics' Shares Outstanding (Weighted Average) averaged around $84.8 million, with its median value being $82.2 million (2023).
  • Data for Myriad Genetics' Shares Outstanding (Weighted Average) shows a peak YoY rose of 10.75% (in 2024) over the last 5 years.
  • Yearly analysis of 5 years shows Myriad Genetics' Shares Outstanding (Weighted Average) stood at $74.6 million in 2020, then reached $75.2 million in 2020, then increased by 6.17% to $79.9 million in 2021, then climbed by 1.48% to $81.0 million in 2022, then increased by 1.44% to $82.2 million in 2023, then rose by 10.75% to $91.0 million in 2024.